Containers and methods for storing and admixing medical solutions
First Claim
Patent Images
1. The method for providing nutrition to patient comprising the steps of:
- providing a container having a first chamber and a second chamber, the first chamber containing lipids, a first peelable seal separating the first chamber from the second chamber, the lipid having a concentration of 2,6-di-t-butyl-4-methyl-phenol of less than 0.050 μ
g/ml after the container has been autoclaved at 121°
C. and allowed to stand for 48 hours at ambient temperature;
mixing the contents of the container; and
administering the resultant liquid to the patient.
0 Assignments
0 Petitions
Accused Products
Abstract
Containers and methods for storing medical solutions are provided. More specifically, containers and methods for storing components that are to be admixed together to create a final solution, one of the components comprising a lipid. In an embodiment, a container including an interior defining at least two chambers. The first chamber includes a lipid containing liquid. The second chamber includes a liquid that does not include a lipid. The first and second chambers are separated by an openable seal.
197 Citations
6 Claims
-
1. The method for providing nutrition to patient comprising the steps of:
-
providing a container having a first chamber and a second chamber, the first chamber containing lipids, a first peelable seal separating the first chamber from the second chamber, the lipid having a concentration of 2,6-di-t-butyl-4-methyl-phenol of less than 0.050 μ
g/ml after the container has been autoclaved at 121°
C. and allowed to stand for 48 hours at ambient temperature;
mixing the contents of the container; and
administering the resultant liquid to the patient.
-
-
2. A method for providing nutrition to a patient comprising the steps of:
-
providing a container having a first chamber and a second chamber, the first chamber containing lipids, a first peelable seal separating the first chamber from the second chamber, the lipid having a concentration of 2,6-di-t-butyl-4-ethylphenol of less than 0.011 μ
g/ml after the container has been autoclaved at 121°
C. and allowed to stand for 48 hours at ambient temperature;
mixing the contents of the container; and
administering the resultant liquid to the patient.
-
-
3. A method for providing nutrition to a patient comprising the steps of:
-
providing a container having a first chamber and a second chamber, the first chamber containing lipids, a first peelable seal separating the first chamber from the second chamber, the lipid having a concentration of 25-crown-5 ether of less than 0.01 μ
g/ml after the container has been autoclaved at 121°
C. and allowed to stand for 48 hours at ambient temperature;
mixing the contents of the container; and
administering the resultant liquid to the patient.
-
-
4. A method for providing nutrition to a patient comprising the steps of:
-
providing a container having a first chamber and a second chamber, the first chamber containing lipids, a first peelable seal separating the first chamber from the second chamber, the lipid having a concentration of aluminum of less than 0.023 μ
g/ml after the container has been autoclaved at 121°
C. and allowed to stand for 48 hours at ambient temperature;
mixing the contents of the container; and
administering the resultant liquid to the patient.
-
-
5. A method for providing nutrition to a patient comprising the steps of:
-
providing a container having a first chamber and a second chamber, the first chamber containing lipids, a first peelable seal separating the first chamber from the second chamber, the lipid having a concentration of oligomeric propylene of less than 5.6 μ
g/ml after the container has been autoclaved at 121°
C. and allowed to stand for 48 hours at ambient temperature;
mixing the contents of the container; and
administering the resultant liquid to the patient.
-
-
6. A method for providing nutrition to a patient comprising the steps of:
-
providing a container having a first chamber and a second chamber, the first chamber containing lipids, a first peelable seal separating the first chamber from the second chamber, the lipid having a concentration of oligomeric ethylene vinyl acetate of less than 5.6 μ
g/ml after the container has been autoclaved at 121°
C. and allowed to stand for 48 hours at ambient temperature;
mixing the contents of the container; and
administering the resultant liquid to the patient.
-
Specification